{"organizations": [], "uuid": "70ad39de08c1ef0dbc3cf02a5c0843c1b49f8986", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-theravance-biopharma-q4-revenue-45/brief-theravance-biopharma-q4-revenue-4-5-million-idUSASB0C7TD", "country": "US", "domain_rank": 408, "title": "BRIEF-Theravance Biopharma Q4 Revenue $4.5 Million", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-28T00:09:00.000+02:00", "replies_count": 0, "uuid": "70ad39de08c1ef0dbc3cf02a5c0843c1b49f8986"}, "author": "", "url": "https://www.reuters.com/article/brief-theravance-biopharma-q4-revenue-45/brief-theravance-biopharma-q4-revenue-4-5-million-idUSASB0C7TD", "ord_in_thread": 0, "title": "BRIEF-Theravance Biopharma Q4 Revenue $4.5 Million", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters staff", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "theravance biopharma inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Theravance Biopharma Inc:\n* THERAVANCE BIOPHARMA, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE\n* Q4 REVENUE $4.5 MILLION * ‍ANTICIPATES FULL YEAR 2018 OPERATING LOSS, EXCLUDING SHARE-BASED COMPENSATION, WILL BE IN RANGE OF $180.0 TO $200.0 MILLION​\n* QTRLY ‍LOSS PER SHARE $1.64​ Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-28T00:09:00.000+02:00", "crawled": "2018-02-28T00:22:15.008+02:00", "highlightTitle": ""}